课题基金 / 基金详情

Genomic analysis of microphthalmia, anophthalmia and coloboma

Genomic analysis of microphthalmia, anophthalmia and coloboma
小眼症、无眼症和缺损的基因组分析
批准号:
10280960
负责人:
ANNE M. SLAVOTINEK
金额:
$47.67万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-08-31
关键词:
AffectAnimal ModelAnophthalmosArchitectureBilateralBiologicalBiological AssayBiological ModelsBiologyCRISPR/Cas technologyCandidate Disease GeneCatalogsCategoriesCellsClinical ManagementClustered Regularly Interspaced Short Palindromic RepeatsCodeCollaborationsColobomaColorCongenital AbnormalityCopy Number PolymorphismCytogeneticsDataData SetDefectDevelopmentDevelopmental BiologyDiagnosisDideoxy Chain Termination DNA SequencingDominant-Negative MutationEvaluationExonsEyeEye DevelopmentEye diseasesFailureFamily memberFissuralFutureGene ExpressionGene Transfer TechniquesGenesGeneticGenetic HeterogeneityGenetic Predisposition to DiseaseGenomicsGenotypeImmunohistochemistryImpairmentIn VitroInjectionsInvestigationKaryotypeKnowledgeLarvaMedical GeneticsMethodologyMicrophthalmosModelingMorphogenesisMorphologyNucleic Acid Regulatory SequencesNucleotidesOligonucleotidesOpticsParentsPathogenesisPathogenicityPatient CarePatientsPhenotypePrognosisQuality of lifeRNARNA SplicingRegulatory ElementReporterResearch PersonnelResearch SupportResourcesReverse Transcriptase Polymerase Chain ReactionRiskRoleSiteSpliced GenesStructureTestingTherapeutic TrialsTimeUntranslated RNAValidationVariantVisionVisual impairmentWorkZebrafishcausal variantexome sequencingexperiencegain of functiongenetic testinggenetic variantgenome sequencinggenomic datagenomic variationimprovedin silicoin vivoinsertion/deletion mutationloss of functionmalformationmedical complicationmutantnovelprogramssegregationspatiotemporaltherapy developmenttranscription factortranscriptome sequencingwhole genome

项目摘要

项目成果

ANNE M. SLAVOTINEK的其他基金

相似基金

相关文献

中文摘要
翻译
总结
英文摘要
SUMMARY Microphthalmia, anophthalmia and coloboma (MAC) are highly important birth defects because of the lifelong effects of severely reduced vision. MAC can be caused by pathogenic sequence variants and copy number variants affecting transcription factors and other genes involved in eye development. Patients with MAC typically undergo genetic testing with microarrays, gene panels and exome sequencing, but a genetic etiology is not identified for many patients. A complete catalogue of the genomic variation underlying MAC is critical for optimizing patient care, facilitating future therapeutic trials and to provide novel information supporting research into the developmental biology of eye defects. In this proposal, we will use whole genome sequencing (WGS) and in vitro and in vivo functional studies to advance our understanding of the genomic architecture of MAC. Our first Aim involves the use of WGS to obtain complete genomic data, including coding and non-coding sequence variants, copy number variants and structural cytogenetic variation, in a minimum of 200 patients with MAC. We will prioritize patients with MAC who have multiple affected family members, consanguineous parents, bilateral eye involvement, and negative prior genetic testing. This aim will enable us to investigate the full range of genomic variation in MAC and to determine whether non-coding variation and structural cytogenetic variation contribute to the genetic etiology of these birth defects. In our second Aim, we will use zebrafish with CRISPR to investigate the effects of loss and gain of function for novel candidate genes for MAC and to determine the effects of specific, coding sequence variants on eye development. We will comprehensively phenotype control and mutant larvae and perform RNA-Seq to study alterations in downstream gene expression. We will also study non-coding variation by performing RT-PCR in patient cells, minigene assays and CRISPR/Cas9 with dual reporter transgenesis assays in zebrafish. Our results will generate comprehensive data on the genomic variation that can cause MAC and will provide functional validation of novel genes and variants. This proposal will substantially improve our understanding of eye development, in addition to generating rich resources for future investigations and collaborations between clinicians, developmental biologists and eye researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microphthalmia, anophthalmia and coloboma (MAC) and retinoic acid pathway genes
  • 批准号:
    10738019
  • 项目类别:
  • 资助金额:
    $36.11万
  • 财政年份:
    2023
  • 负责人:
    ANNE M. SLAVOTINEK
  • 依托单位:
Genomic analysis of microphthalmia, anophthalmia and coloboma
  • 批准号:
    10746478
  • 项目类别:
  • 资助金额:
    $46.24万
  • 财政年份:
    2021
  • 负责人:
    ANNE M. SLAVOTINEK
  • 依托单位:
Genomic analysis of microphthalmia, anophthalmia and coloboma
  • 批准号:
    10914942
  • 项目类别:
  • 资助金额:
    $32.73万
  • 财政年份:
    2021
  • 负责人:
    ANNE M. SLAVOTINEK
  • 依托单位:
Gene Discovery in Human Anopthalmia/Micropthalmia
海外基金